Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2021
Pharma News, 2021
Scientists develop vaccine strategy for urinary tract infections
Anyone who has ever developed a urinary tract infection (UTI) knows that it can be painful, pesky and persistent.
Merck agrees $1 billion deal with Debiopharm for head and neck cancer drug
BERLIN (Reuters) - Germany’s Merck KGgA said on Monday it has agreed to pay Swiss biotech Debiopharm up to 900 million euros ($1.
FDA approves first liquid-filled aspirin capsule
PLx Pharma has won FDA approval for its liquid-filled aspirin capsule Vazalore.
FDA approves device designed to protect athletes from traumatic brain injuries
According to CNN a new device, designed to prevent traumatic brain injuries (TBIs), has been approved by the US Food and Drug Administration (FDA).
FDA approves at-home COVID test
An at-home test for coronavirus Monday won emergency use approval from the federal Food and Drug Administration.
FDA approves first treatment for Molybdenum Cofactor Deficiency Type A
The US Food and Drug Administration has approved the first treatment for the rare genetic disorder Molybdenum Cofactor Deficiency Type A.
Santhera Announces Positive Results with Lonodelestat in Early Phase Cystic Fibrosis Trial
PRATTELN, Switzerland I March 1, 2021 I Santhera Pharmaceuticals (SIX.
Coronavirus (COVID-19) Update: FDA Allows More Flexible Storage, Transportation Conditions for Pfizer-BioNTech COVID-19 Vaccine
Today, the U.
Congo confirms three new Ebola cases
GOMA, Democratic Republic of Congo (Reuters) - Three new cases of Ebola have been confirmed in eastern Democratic Republic of Congo, bringing to 11 the number of cases since authorities declar...
FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine
Today, the U.
Japan's Takeda sells four diabetes products to Teijin Pharma for $1.25 billion
TOKYO (Reuters) - Takeda Pharmaceutical Co said on Friday it agreed to sell four diabetes products in Japan to Teijin Pharma Ltd for 133 billion yen ($1.
Pfizer to test third dose, tweaked vaccine to target S.African strain
Concerns have risen that more transmissible coronavirus variants such as the one first detected in South Africa or another in Britain are more resistant to existing vaccines such as the one developed ...
62
63
64
65
66
67
68
69
70
